Saw palmetto GI adverse events could trigger NTP carcinogenicity, toxicity review.
This article was originally published in The Tan Sheet
Executive Summary
SAW PALMETTO GI ADVERSE REACTIONS MOST COMMON EVENT reported in a review of human data for the dietary supplement ingredient prepared by Integrated Laboratory Systems on behalf of the National Institute for Environmental Health Sciences. The report -- and two similar reviews of goldenseal and comfrey -- formed part of the basis for the National Toxicology Program Interagency Committee for Chemical Evaluation and Coordination recommendation that the three supplement ingredients and some of their respective constituents receive consideration for in vivo carcinogenicity and reproductive toxicity tests ("The Tan Sheet" Jan. 12, p. 13). The testing recommendations were published in the Jan. 8 Federal Register and are subject to a 60-day public comment period.